This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1978 Mar 11;1(6113):622.

doi: 10.1136/bmj.1.6113.622.

Naftidrofuryl for intermittent claudication: a double-blind controlled trial

C V Ruckley, M J Callam, C M Ferrington, R J Prescott

PMID: 343869
PMCID: PMC1603360
DOI: 10.1136/bmj.1.6113.622

Clinical Trial

Naftidrofuryl for intermittent claudication: a double-blind controlled trial

C V Ruckley et al. Br Med J. 1978.

. 1978 Mar 11;1(6113):622.

doi: 10.1136/bmj.1.6113.622.

Authors

C V Ruckley, M J Callam, C M Ferrington, R J Prescott

PMID: 343869
PMCID: PMC1603360
DOI: 10.1136/bmj.1.6113.622

No abstract available

PubMed Disclaimer

Similar articles

[Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
Valentin A, Karnik R, Stöllberger C, Slany J. Valentin A, et al. Vasa Suppl. 1987;20:361-4. Vasa Suppl. 1987. PMID: 3321493 Clinical Trial. German. No abstract available.
A controlled trial of naftidrofuryl (Praxilene) in the treatment of intermittent claudication.
Clyne CA, Galland RB, Fox MJ, Gustave R, Jantet GH, Jamieson CW. Clyne CA, et al. Br J Surg. 1980 May;67(5):347-8. doi: 10.1002/bjs.1800670515. Br J Surg. 1980. PMID: 6992909 Clinical Trial.
The effect of naftidrofuryl (Praxilene) on intermittent claudication.
Waters KJ, Craxford AD, Chamberlain J. Waters KJ, et al. Br J Surg. 1980 May;67(5):349-51. doi: 10.1002/bjs.1800670516. Br J Surg. 1980. PMID: 6992910 Clinical Trial.
Naftidrofuryl: a review of its use in the treatment of intermittent claudication.
Goldsmith DR, Wellington K. Goldsmith DR, et al. Drugs Aging. 2005;22(11):967-77. doi: 10.2165/00002512-200522110-00006. Drugs Aging. 2005. PMID: 16323973 Review.
The limits of evidence in drug approval and availability: a case study of cilostazol and naftidrofuryl for the treatment of intermittent claudication.
Hong H, Mackey WC. Hong H, et al. Clin Ther. 2014 Aug 1;36(8):1290-301. doi: 10.1016/j.clinthera.2014.06.010. Epub 2014 Jul 8. Clin Ther. 2014. PMID: 25012728 Review.

See all similar articles

Cited by

Naftidrofuryl for intermittent claudication.
de Backer TL, Vander Stichele R, Lehert P, Van Bortel L. de Backer TL, et al. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD001368. doi: 10.1002/14651858.CD001368.pub4. Cochrane Database Syst Rev. 2012. PMID: 23235580 Free PMC article.
Pharmacological approaches to the treatment of intermittent claudication.
Bevan EG, Waller PC, Ramsay LE. Bevan EG, et al. Drugs Aging. 1992 Mar-Apr;2(2):125-36. doi: 10.2165/00002512-199202020-00006. Drugs Aging. 1992. PMID: 1596595 Review.
Claudication.
Ruckley VC. Ruckley VC. Br Med J (Clin Res Ed). 1986 Apr 12;292(6526):970-1. doi: 10.1136/bmj.292.6526.970. Br Med J (Clin Res Ed). 1986. PMID: 3083974 Free PMC article. No abstract available.
Oral naftidrofuryl. A review of its pharmacology and therapeutic use in the management of peripheral occlusive arterial disease.
Barradell LB, Brogden RN. Barradell LB, et al. Drugs Aging. 1996 Apr;8(4):299-322. doi: 10.2165/00002512-199608040-00005. Drugs Aging. 1996. PMID: 8920176 Review.

References

1. Br J Surg. 1971 Jul;58(7):532-7 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central